Book Appointment
Bladder cancer is the most treatable urological cancer when detected early. Urothelial carcinoma accounts for over 90% of cases. Blood in urine, occurring in 80 to 90% of patients, is the most common warning sign and must never be dismissed as a minor cause. Smoking accounts for approximately half of all bladder cancer cases; men over 55 and those with occupational chemical exposure are at additional risk. Diagnosis relies on cystoscopy (gold standard), CT urogram, and urine cytology. Non-muscle-invasive disease is treated with TURBT and intravesical BCG therapy. Muscle-invasive disease requires radical cystectomy with neoadjuvant chemotherapy. Recurrence rates of 30 to 70% make long-term surveillance cystoscopy essential after any bladder cancer treatment.
Bladder cancer is the most common urological cancer after prostate cancer in men, and one of the most treatable when caught early. Many patients delay seeking evaluation because the warning signs are easy to attribute to something less serious. The difference between Stage 1 and Stage 3 outcomes is almost entirely determined by how soon symptoms are investigated.

What Is Bladder Cancer?

Bladder cancer begins when cells lining the inner surface of the bladder grow abnormally. The most common type, urothelial carcinoma, accounts for over 90% of cases. Bladder cancer is classified as non-muscle-invasive (confined to the inner lining) or muscle-invasive (grown deeper into the bladder wall). Non-muscle-invasive cases are highly treatable but recur frequently, requiring long-term surveillance.

Who Is at Risk?

Smoking is responsible for approximately half of all bladder cancer cases. Chemicals in tobacco are filtered into urine, where they come into prolonged contact with the bladder lining. Occupational exposure to aromatic amines in the rubber, leather, textile, and paint industries is the second major risk factor. Recurrent urinary tract infections, bladder stones, or previous pelvic radiation also increase susceptibility. Men are three to four times more likely than women to develop bladder cancer, and risk rises significantly after age 55.

Warning Signs You Should Not Ignore

Blood in urine (hematuria) is the most common and important warning sign, occurring in 80 to 90% of cases. It may be visible (pink, red, or brown urine) or detectable only on urine testing. Visible blood in urine, even once and without pain, must never be dismissed without investigation.

 

New persistent urinary urgency or frequency without an obvious infection can indicate a bladder tumour or carcinoma in situ irritating the bladder lining.

 

Pelvic or back pain occurring with urinary symptoms in older patients or smokers warrants prompt assessment.

 

Recurrent urinary tract infections that do not resolve fully or keep returning should be evaluated to rule out an underlying bladder abnormality.

Why These Symptoms Are Often Dismissed

Blood in urine is frequently attributed to a urinary tract infection or kidney stones without proper investigation. Urgency and frequency are assumed to be overactive bladder and treated with medication. This delayed investigation is the primary reason bladder cancer is often found at a more advanced stage than necessary. Any visible blood in urine in any adult warrants cystoscopy regardless of another apparent explanation.

How Bladder Cancer Is Diagnosed

Urine cytology examines urine for abnormal cancer cells but misses some low-grade tumours. Cystoscopy is the gold standard: a flexible camera passed through the urethra directly visualises the bladder lining and detects tumours and carcinoma in situ that imaging may miss. CT urogram assesses the kidneys, ureters, and bladder and detects spread. Biopsy during TURBT provides the definitive diagnosis and determines tumour depth and grade.

Gurukrupa Urology Clinic is located at Shop No-204, 1st Floor, Matrix Business Centre, Amarpreet-Roplekar Road, Kalda Corner, Chhatrapati Sambhajinagar, Maharashtra. Dr Mayur Dalvi (MBBS, MS General Surgery, MCh Urology) provides cystoscopy, urine cytology, CT urogram, TURBT, intravesical therapy, and complete bladder cancer surveillance. Clinic hours: 6:00 PM to 9:00 PM. Contact: +91 9096894897 / +91 8177884043. Website: drmayurdalvi.com.

How Bladder Cancer Is Treated

TURBT (transurethral resection of bladder tumour) is the primary treatment for non-muscle-invasive bladder cancer. It is performed through the urethra under anaesthesia; the tumour is removed and invasion depth is assessed.

 

Following TURBT, intravesical therapy is instilled directly into the bladder. BCG immunotherapy is standard for high-risk disease; Mitomycin C for lower-risk cases.

 

For muscle-invasive bladder cancer, radical cystectomy combined with neoadjuvant chemotherapy is the standard. Bladder-preserving chemo-radiation is an alternative in selected cases.

Long-term surveillance cystoscopy is essential for all patients due to the high recurrence rate.

Who Should See a Urologist Without Delay?

Anyone with visible blood in urine, even once. Adults over 55 with new urinary urgency or frequency without infection. Smokers with any urinary change. Patients with recurrent UTIs that do not resolve. Workers in chemical, rubber, or paint industries with any urinary symptom. Do not attribute blood in urine to a minor cause without cystoscopy.

Consult Dr Mayur Dalvi at Gurukrupa Urology Clinic

If you have noticed blood in urine, recurring urinary symptoms, or any of the warning signs described above, Dr Mayur Dalvi at Gurukrupa Urology Clinic provides comprehensive urology evaluation including cystoscopy, CT urogram, urine cytology, TURBT, and long-term bladder cancer surveillance.

 

Gurukrupa Urology Clinic | Shop No-204, 1st Floor, Matrix Business Centre, Amarpreet-Roplekar Road, Kalda Corner, Chhatrapati Sambhajinagar | 6:00 PM to 9:00 PM

Call +91 9096894897 | +91 8177884043

FREQUENTLY ASKED QUESTIONS

Q1: What is the most common warning sign of bladder cancer?
Blood in urine (hematuria) is the most common sign, occurring in 80 to 90% of bladder cancer cases. It may be visible as pink, red, or brown urine, or detectable only on urine testing. Even a single episode of visible blood in urine in an adult must be investigated by a urologist without delay.

 

Q2: Can bladder cancer be present without blood in urine?
Yes, though it is less common. Some bladder cancers, particularly carcinoma in situ, present with urinary urgency and frequency without visible blood. Microscopic hematuria (blood detectable only on testing) may also be present without obvious discolouration of urine. Any new persistent urinary symptoms warrant evaluation.

 

Q3: Is blood in urine always caused by bladder cancer?
No. Blood in urine has many causes including kidney stones, urinary tract infections, kidney disease, and prostate conditions. However, bladder cancer is a serious cause that must be ruled out, especially in adults over 40, smokers, and those with occupational chemical exposures. A cystoscopy provides a definitive answer.

 

Q4: What causes bladder cancer?
Smoking is responsible for approximately half of bladder cancer cases. Occupational exposure to aromatic amines in the rubber, leather, paint, and textile industries is the second major cause. Recurrent urinary tract infections, pelvic radiation, and certain chemotherapy drugs also increase risk. Men are three to four times more likely than women to develop it.

 

Q5: What is cystoscopy and does it hurt?
Cystoscopy is a diagnostic procedure in which a thin flexible camera is passed through the urethra into the bladder to directly visualise the lining. It is performed under local anaesthesia as an outpatient procedure and causes mild discomfort rather than significant pain. It is the most accurate method for detecting bladder tumours.

 

Q6: What is TURBT?
TURBT (transurethral resection of bladder tumour) is the primary surgical treatment for non-muscle-invasive bladder cancer. It is performed through the urethra under anaesthesia. The tumour is removed using an electrical loop, and the depth of tumour invasion is assessed. Most patients go home the same day or after one night.

 

Q7: Does bladder cancer come back after treatment?
Yes, bladder cancer has one of the highest recurrence rates of any cancer, particularly non-muscle-invasive disease. After TURBT, recurrence rates range from 30 to 70% depending on tumour grade and stage. This is why regular surveillance cystoscopy every 3 to 12 months for years after treatment is essential for all bladder cancer patients.

 

Q8: Can bladder cancer be cured?
Non-muscle-invasive bladder cancer has excellent cure rates with TURBT and intravesical therapy. Muscle-invasive bladder cancer treated with radical cystectomy has five-year survival rates of approximately 50 to 65% depending on stage. Early detection is the strongest determinant of outcome.

 

Q9: Who is at highest risk for bladder cancer?
Long-term smokers, men over age 55, workers in chemical and manufacturing industries, people with a history of recurrent urinary tract infections, those who have received pelvic radiation, and patients who have taken certain chemotherapy drugs are at the highest risk.

 

Q10: Where can I see a bladder cancer specialist in Aurangabad?
Dr Mayur Dalvi at Gurukrupa Urology Clinic, Kalda Corner, Chhatrapati Sambhajinagar, provides cystoscopy, TURBT, CT urogram, and complete bladder cancer evaluation and management. Call +91 9096894897 or visit drmayurdalvi.com.

This article is authored by Dr Mayur Dalvi, Urologist at Gurukrupa Urology Clinic, Chhatrapati Sambhajinagar. Content is based on American Urological Association guidelines on non-muscle invasive bladder cancer, European Association of Urology urothelial carcinoma guidelines, and National Cancer Institute bladder cancer data.

Recent Post

Contact Us Today

Copyright © 2024 Dr. Mayur Dalvi | Developed By - Cloud Nexus Digital Solution